american academy of cardiology glp 1 The conversation around GLP-1 medications is growing, and it goes beyond the number on the scale. According to the Heart Association, evidence suggests GLP-1s may support heart health and help reduce 2019 ACC/AHA Guideline on the

While semaglutide itself does not directly cause photosensitivity, the profound physiological changes brought about by rapid weight loss, the challenges of maintaining hydration amidst GI side effects, and the potential for photosensitizing co-medications can significantly increase an individual's vulnerability to UV damage

Personalized Obesity Care Medication, ESG, gastric balloons, and combination care may each have a role depending on the individual patient

Their follicles were accustomed to a high-insulin, high-IGF-1 environment, and the correction of this environment, while metabolically beneficial, may temporarily disadvantage hair growth

The Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS) is a study comparing sitagliptin with placebo in diabetic patients with a previous history of cardiovascular disease